Estimations des analystes de Wall Street pour Alterity Therapeutics Limited (ATHE): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2027-03-04 | $-0.03 | ||
| 2026-08-28 | $-0.05 | $-0.12 | +59.2% |
| 2026-02-25 | $-0.42 | $-0.25 | -65.9% |
| 2025-08-28 | $-0.34 | $-0.56 | +39.5% |
| 2025-08-04 | |||
| 2025-02-28 | $-0.57 | $-0.69 | +18.4% |
| 2025-02-03 | $-0.00 | ||
| 2024-08-29 | $-0.80 | $-0.07 | -1067.4% |
Ratios de valorisation
| Prix / Valeur comptable | 2.73 |
| EV / EBITDA | -3.58 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $132396 | $201174 | $108538 | 0 | $4.3M | $5.1M | $3.9M | $4.0M | $5.4M | 0 |
| Coût des Ventes | $21328 | $21799 | $29696 | $112427 | $360026 | $364665 | $285067 | $214304 | $127523 | $113010 |
| Marge Brute | $111068 | $179375 | $78842 | -$112427 | $4.0M | $4.8M | $3.6M | $3.8M | $5.3M | -$113010 |
| R&D | $5.7M | $6.7M | $13.0M | $10.1M | $12.3M | $14.7M | $13.2M | $18.6M | $14.4M | $17.2M |
| Frais Généraux | $3.9M | $4.3M | $4.3M | $3.3M | $6.9M | $5.5M | $5.0M | $4.8M | $5.5M | $10.4M |
| Charges Opérationnelles | $6.8M | $11.1M | $12.5M | $10.1M | $19.2M | $20.3M | $18.2M | $23.4M | $19.9M | $27.7M |
| Résultat Opérationnel | -$6.9M | -$7.8M | -$12.7M | -$10.4M | -$15.2M | -$15.5M | -$14.6M | -$19.6M | -$14.6M | -$27.8M |
| EBITDA | -$6.9M | -$11.4M | -$12.8M | -$13.3M | -$15.2M | -$17.4M | -$14.6M | -$19.6M | -$14.6M | -$27.7M |
| Charges d'Intérêt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Avant Impôts | -$7.5M | -$8.3M | -$12.3M | -$10.1M | -$15.3M | -$12.8M | -$13.7M | -$19.1M | -$12.1M | -$26.3M |
| Impôts | $660213 | -$495440 | -$376031 | -$362188 | -$3.1M | $70008 | $104459 | $46088 | $68055 | -$3.4M |
| Résultat Net | -$7.5M | -$8.3M | -$12.0M | -$10.1M | -$15.3M | -$12.8M | -$13.8M | -$19.1M | -$12.1M | -$22.9M |
| BPA | $-8.46 | $-9.30 | $-11.64 | $-6.48 | $-5.40 | $-3.18 | $-3.42 | $-3.12 | $-1.14 | $-1.32 |
| BPA Dilué | $-8.46 | $-9.30 | $-11.64 | $-6.48 | $-5.40 | $-3.18 | $-3.42 | $-3.12 | $-1.14 | $-1.32 |
| Actions en Circulation (Diluées) | $889819 | $889819 | $1.0M | $1.5M | $2.8M | $4.0M | $4.0M | $6.1M | $10.7M | $17.5M |
Prix
| Prix | $3.85 |
| Capitalisation | $65M |
| Bourse | NASDAQ |
| Pays | AU |
Entreprises liées: ANVS · BTAI · DYAI · EVAX · GBIO · IGC · LIMN
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ATHE: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions